| scholarly article | Q13442814 |
| P50 | author | Ilya Frolov | Q42428105 |
| P2093 | author name string | M Chen | |
| Y Ji | |||
| S W Barnett | |||
| M A Liu | |||
| S Perri | |||
| G R Otten | |||
| J M Polo | |||
| J P Gardner | |||
| C E Greer | |||
| S Sherrill | |||
| B A Belli | |||
| D A Driver | |||
| T W Dubensky | |||
| J zur Megede | |||
| M L MacKichan | |||
| P2860 | cites work | Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope | Q24652858 |
| Binding of Sindbis virus to cell surface heparan sulfate | Q27469562 | ||
| Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation | Q27469619 | ||
| Molecular basis of Sindbis virus neurovirulence in mice | Q27486828 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| The alphaviruses: gene expression, replication, and evolution | Q27860954 | ||
| Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
| Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells | Q57275942 | ||
| DNA-based immunization by in vivo transfection of dendritic cells | Q71607054 | ||
| Antigen-bearing Langerhans cells in skin draining lymph nodes: phenotype and kinetics of migration | Q72082499 | ||
| Reciprocal control of T helper cell and dendritic cell differentiation | Q74452751 | ||
| Molecular analysis of Sindbis virus pathogenesis in neonatal mice by using virus recombinants constructed in vitro | Q28776698 | ||
| Complete nucleotide sequence of the genomic RNA of Sindbis virus | Q29615023 | ||
| A new generation of animal cell expression vectors based on the Semliki Forest virus replicon | Q30014839 | ||
| Dendritic cell vaccines for cancer immunotherapy | Q33540299 | ||
| T lymphocyte responses in HIV-1 infection: implications for vaccine development | Q33711396 | ||
| Alphavirus vectors for gene expression and vaccines | Q33744836 | ||
| Cell-based vaccination against melanoma--background, preliminary results, and perspective | Q33763856 | ||
| Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis | Q33796546 | ||
| Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene | Q33799802 | ||
| DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector | Q34069023 | ||
| The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing | Q34310837 | ||
| Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. | Q34479873 | ||
| Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. | Q34527878 | ||
| Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors | Q35134462 | ||
| DNA vaccination: transfection and activation of dendritic cells as key events for immunity | Q35834601 | ||
| Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice | Q35848499 | ||
| Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA | Q35880542 | ||
| Maturation, activation, and protection of dendritic cells induced by double-stranded RNA | Q36367830 | ||
| Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells | Q36380589 | ||
| Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells | Q36380614 | ||
| Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. | Q36401759 | ||
| Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. | Q36438020 | ||
| Laser scanning cytometry in pathology of solid tumors. A review | Q36845300 | ||
| Phenotypic characteristics of antigen-bearing cells in the draining lymph nodes of contact sensitized mice | Q38515857 | ||
| Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. | Q39580237 | ||
| Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. | Q39873145 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs | Q41057373 | ||
| Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo | Q41071177 | ||
| Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene | Q41572703 | ||
| Interactions of viruses with dendritic cells: a double-edged sword | Q41614150 | ||
| Regulators of apoptosis on the road to persistent alphavirus infection | Q41620682 | ||
| Antigenic and genetic characterization of Sindbis virus monoclonal antibody escape mutants which define a pathogenesis domain on glycoprotein E2. | Q41741530 | ||
| Mobilizing dendritic cells for tolerance, priming, and chronic inflammation | Q42576422 | ||
| Sindbis virus: an efficient, broad host range vector for gene expression in animal cells | Q42991441 | ||
| Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. | Q45745921 | ||
| Inhibition of dendritic cell maturation by herpes simplex virus | Q45746588 | ||
| Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. | Q54451826 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| vector-borne disease | Q2083837 | ||
| Sindbis virus | Q2302993 | ||
| P304 | page(s) | 11849-11857 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein | |
| P478 | volume | 74 |
| Q42983982 | A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy |
| Q45213829 | A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge |
| Q33769306 | A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles |
| Q30708628 | A high-throughput alphavirus-based expression cloning system for mammalian cells. |
| Q33316163 | A two-phase innate host response to alphavirus infection identified by mRNP-tagging in vivo. |
| Q37995803 | Alphavirus replicon vaccines |
| Q34812016 | Alphavirus vectors and vaccination |
| Q34130212 | Alphavirus vectors for cancer therapy. |
| Q35194202 | Alphavirus vectors for vaccine production and gene therapy |
| Q30771556 | Alphavirus vectors: development and potential therapeutic applications |
| Q38574574 | Alphavirus-based vaccines in melanoma: rationale and potential improvements in immunotherapeutic combinations |
| Q27473379 | American Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic Cells |
| Q26777943 | An Overview of Challenges Limiting the Design of Protective Mucosal Vaccines for Finfish |
| Q36524157 | An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector |
| Q37288017 | Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems |
| Q44462964 | Assessing the feasibility of using neural precursor cells and peripheral blood mononuclear cells for detection of bioactive Sindbis virus |
| Q34976024 | Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats |
| Q45656920 | Attenuation of Sindbis virus variants incorporating uncleaved PE2 glycoprotein is correlated with attachment to cell-surface heparan sulfate |
| Q37765475 | Biology and pathogenesis of chikungunya virus |
| Q21090531 | Characterization of reemerging chikungunya virus |
| Q24288996 | Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages |
| Q37416110 | Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects |
| Q28752489 | Comparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in mice |
| Q27486897 | DC-SIGN and L-SIGN Can Act as Attachment Receptors for Alphaviruses and Distinguish between Mosquito Cell- and Mammalian Cell-Derived Viruses |
| Q35108541 | DNA vaccines and apoptosis: to kill or not to kill? |
| Q35758746 | DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection |
| Q39732678 | Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs- HSV vectors for dendritic cell-mediated immunotherapy |
| Q38352161 | Deletions in the putative cell receptor-binding domain of Sindbis virus strain MRE16 E2 glycoprotein reduce midgut infectivity in Aedes aegypti |
| Q46932503 | Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma |
| Q37620817 | Design of a novel integration-deficient lentivector technology that incorporates genetic and posttranslational elements to target human dendritic cells |
| Q38695329 | Distinctive Responses in an In Vitro Human Dendritic Cell-Based System upon Stimulation with Different Influenza Vaccine Formulations |
| Q36539048 | Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques |
| Q36949568 | Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis. |
| Q42256790 | Engineered alphavirus replicon vaccines based on known attenuated viral mutants show limited effects on immunogenicity |
| Q34531924 | Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A |
| Q42847157 | Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins |
| Q45723766 | Human immunodeficiency virus type 1 envelope-mediated neuropathogenesis: targeted gene delivery by a Sindbis virus expression vector |
| Q36498186 | Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business". |
| Q27485003 | Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA Vaccine |
| Q40581836 | Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming |
| Q40263989 | Inhibition of type I allergic responses with nanogram doses of replicon-based DNA vaccines. |
| Q37500317 | Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion |
| Q27472866 | Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity |
| Q36377208 | Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications |
| Q36086236 | Lack of interference with immunogenicity of a chimeric alphavirus replicon particle-based influenza vaccine by preexisting antivector immunity |
| Q37677792 | Lentiviral vectors for immune cells targeting |
| Q35027794 | Lipopolysaccharide inhibits Sindbis virus-induced IP-10 release in human peripheral blood mononuclear cells |
| Q45399630 | Long-term protection in hamsters against human parainfluenza virus type 3 following mucosal or combinations of mucosal and systemic immunizations with chimeric alphavirus-based replicon particles |
| Q33920185 | Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles |
| Q27675076 | Molecular Links between the E2 Envelope Glycoprotein and Nucleocapsid Core in Sindbis Virus |
| Q35953762 | Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines |
| Q35134733 | Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges |
| Q39787669 | Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes. |
| Q42326934 | New applications of alphavirus-based expression vectors |
| Q27015034 | Phosphatidylserine receptors: enhancers of enveloped virus entry and infection |
| Q38586243 | Protective and Pathogenic Responses to Chikungunya Virus Infection |
| Q35496414 | Pseudotyping lentiviral vectors with aura virus envelope glycoproteins for DC-SIGN-mediated transduction of dendritic cells |
| Q37945198 | RNA replicons - a new approach for influenza virus immunoprophylaxis |
| Q34786990 | Recent advances in mucosal vaccines and adjuvants |
| Q40561849 | Receptor-dependent coronavirus infection of dendritic cells |
| Q34355773 | Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection |
| Q35043098 | Selectively replicating viral vectors |
| Q37690452 | Sindbis viral vectors transiently deliver tumor-associated antigens to lymph nodes and elicit diversified antitumor CD8+ T-cell immunity |
| Q40286302 | Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity |
| Q33718551 | Sindbis virus translation is inhibited by a PKR/RNase L-independent effector induced by alpha/beta interferon priming of dendritic cells |
| Q40416025 | Targeting Sindbis virus-based vectors to Fc receptor-positive cell types |
| Q58750585 | The Journey of Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road |
| Q45722894 | Use of a Sindbis virus DNA-based expression vector for induction of protective immunity against pseudorabies virus in pigs |
| Q36780156 | Use of viral vectors for the development of vaccines |
| Q34332708 | Vaccines for the prevention of HIV-1 disease |
| Q34731403 | Virus-based vectors for human vaccine applications |
| Q91901320 | mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases |
Search more.